Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atavistic Chemotherapy in Advanced Cancer
NCT02366884Phase 2Unknown
- Sponsor
- Dr. Frank Arguello Cancer Clinic
- Start
- Jul 2011
- Primary completion
- Dec 2022
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline, paromomycin, clarithromycin, clindamycin, dapsone in cancer, sponsored by Dr. Frank Arguello Cancer Clinic. Status: unknown.
02
Drugs
doxycyclineparomomycinclarithromycinclindamycindapsone
03
Conditions
cancer
Beyond the preview
Go deeper on NCT02366884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02366884.